CEO: Italy-made Sputnik V aimed for EU market, if approved | Taiwan News

2021/03/11 02:48
A view of the Adienne Srl plant pharmaceutical company in Caponago, near Milan, Italy, Tuesday, March 9, 2021. Russia signed a deal to produce 10 mill...
A view of the Adienne Srl plant pharmaceutical company in Caponago, near Milan, Italy, Tuesday, March 9, 2021. Russia signed a deal to produce 10 million doses of the Sputnik V coronavirus vaccine in Italy this year. The deal was announced by the Italian-Russian chamber of commerce and signed by Adienne Srl, the Italian subsidiary of a Swiss-based pharmaceutical company and the Russian Direct Investment Fund. (AP Photo/Alberto Pellaschiar)
A view of the Adienne Srl plant pharmaceutical company in Caponago, near Milan, Italy, Tuesday, March 9, 2021. Russia signed a deal to produce 10 mill...

Related Keywords

Italy ,Milan ,Lombardia ,Russia ,Switzerland ,Italian ,Russian ,Swiss ,Alberto Pellaschiar ,Adienne Srl ,Russian Chamber ,European Medicines Agency ,Italian Medicines Agency ,Russian Direct Investment Fund ,Russian Direct Investment ,Antonio Francesco Di Naro ,Associated Press ,Swiss Based Adienne Pharma ,Italian Russian Chamber ,இத்தாலி ,மிலன் ,லோம்பார்டியா ,ரஷ்யா ,சுவிட்சர்லாந்து ,இத்தாலிய ,ரஷ்ய ,சுவிஸ் ,ரஷ்ய அறை ,ரஷ்ய நேரடி முதலீடு நிதி ,ரஷ்ய நேரடி முதலீடு ,அன்டோனியோ பிரான்செஸ்கோ டி நரோ ,தொடர்புடையது ப்ரெஸ் ,இத்தாலிய ரஷ்ய அறை ,